The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Baxter International Inc

NYSE: BAX
Last

(U.S.) $44.82

Today's change+1.44 +3.32%
Updated June 29 3:57 PM EDT. Delayed by at least 15 minutes.
 

Baxter International Inc

NYSE: BAX
Last

(U.S.) $44.82

Today's change+1.44 +3.32%
Updated June 29 3:57 PM EDT. Delayed by at least 15 minutes.

Baxter International Inc crosses above 50-day moving average

Baxter International Inc closed up sharply Wednesday, rallying (U.S.)$1.44 or 3.32% to (U.S.)$44.82 and crossing above its 50-day moving average. Shares have lost 0.27% over the last five days, but have gained 17.48% over the last year to date. This security has underperformed the S&P 500 by 37.17% during the last year.

Key company metrics

  • Open(U.S.) $43.78
  • Previous close(U.S.) $43.38
  • High(U.S.) $44.83
  • Low(U.S.) $43.78
  • Bid / Ask(U.S.) $44.81 / (U.S.) $44.82
  • YTD % change+17.48%
  • Volume3,615,332
  • Average volume (10-day)5,506,785
  • Average volume (1-month)8,652,168
  • Average volume (3-month)8,554,171
  • 52-week range(U.S.) $32.18 to (U.S.) $71.86
  • Beta0.63
  • Trailing P/E6.79×
  • P/E 1 year forward26.49×
  • Forward PEG2.28×
  • Indicated annual dividend(U.S.) $0.52
  • Dividend yield1.16%
  • Trailing EPS(U.S.) $6.61
Updated June 29 3:57 PM EDT. Delayed by at least 15 minutes.
S&P TSX1.38%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue2,3752,6032,4873,893
Total other revenue--------
Total revenue2,3752,6032,4873,893
Gross profit9651,0521,0491,926
Total cost of revenue1,4101,5511,4381,967
Total operating expense2,0862,1882,5253,458
Selling / general / administrative620672670951
Research & development136158140292
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)-80-193277248
Other operating expenses, total--------
Operating income289415-38435
Interest income (expense), net non-operating-33-37-38-40
Gain (loss) on sale of assets--------
Other--------
Income before tax3,329205-33468
Income after tax3,3871832336
Income tax, total-5822-35132
Net income3,3802051332
Total adjustments to net income--------
Net income before extra. items3,3871832336
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items3,3871832336
Inc. avail. to common incl. extra. items3,3802051332
Diluted net income3,3802051332
Dilution adjustment--------
Diluted weighted average shares552552549549
Diluted EPS excluding extraordinary itemsvalue per share6.140.330.000.61
Dividends per sharevalue per share0.120.120.120.52
Diluted normalized EPSvalue per share5.800.020.341.00